GenSpera Receives FDA Clearance to Initiate Phase II Clinical Trials in Prostate Cancer
GenSpera, Inc. (GNSZ-OTC) is one step closer to initiating its planned Phase II human clinical trial of its ...
GenSpera
Healthcare Conferences and News: Week of 1/9 to 1/13
This has been a big week for healthcare and biotech.
Karen Goldfarb
January 13, 2012 at 11:20 AM
Corporate Milestone Update for GenSpera (GNSZ)
Earlier today, GenSpera presented at the Biotech Showcase™ 2012 in San Francisco, California. GenSpera also ...
Karen Goldfarb
January 10, 2012 at 11:21 AM